EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

A Dual-Targeted Therapy with Fucoidan-Functionalized Thrombolytic Discoidal Microparticles for Pulmonary Thromboembolism

Wonseok Choi, Hyeyoun Cho, Hwijin Jang, Hyewon Park, Inchan Youn, Sungmin Han, Jaehong Key iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s527596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Wonseok Choi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bionics Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Polysaccharides, Pulmonary Embolism, Thrombolytic Therapy, Fibrinolytic Agents. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary thromboembolism, a pathological condition characterized by the occlusion of pulmonary vasculature by free-circulating thrombus, constitutes the third leading cause of cardiovascular-related mortality. Among conventional therapeutic approaches to manage the disease, systemic intravenous thrombolysis is hindered by inherent pharmacokinetic and pharmacodynamic limitations, including a short biological half-life, high requisite dosages, and an increased risk of hemorrhagic transformation. Given the critical need for prompt pulmonary reperfusion, this study introduces a dual-targeted therapeutic strategy employing fucoidan-functionalized, thrombolytic discoidal polymeric microparticles. This dual-targeted approach leverages the physicochemical properties of disc-shaped particles, which exhibit shape-dependent accumulation in the lungs, together with the biological binding affinity provided by the marine-derived component, fucoidan.

Methods

A top-down lithographic fabrication technique was employed to synthesize discoidal microparticle systems for physicochemical targeting to the pulmonary vasculature, providing precise control over the system's geometry and uniform drug encapsulation efficiency. Furthermore, a PLGA polymeric matrix was positively modified to incorporate fucoidan onto its matrix surface, which is a sulfated polysaccharide with high-affinity interactions for P-selectin expressed on activated platelets in the nanomolar range. In vitro and in vivo thrombolysis assays were conducted to assess the therapeutic efficacy of microparticles.

Results

The proposed discoidal systems coupled with the fucoidan showed rapid accumulation due to their shape and selective interaction with activated platelets. Approximately 50% of the injected microparticles exhibited preferential accumulation within 15 minutes post-injection, and a significant portion remained over assay times. The fucoidan functionalization enhanced the targeting potential, yielding a 4.65- and 1.48-fold increase under static and dynamic flow assays, respectively (all p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolysaccharidesPulmonary EmbolismThrombolytic TherapyFibrinolytic AgentsAnimalsParticle SizeMiceHumansMaleDose-Response Relationship, DrugDrug Delivery SystemsStructure-Activity Relationship

Stichwörter der Autor:innen

discoidal polymeric particlesdrug delivery systemfucoidanpulmonary thromboembolism

Substanzen

fucoidanPolysaccharidesFibrinolytic Agents

Autor:innen und Institutionen

  • Bionics Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
  • Department of Biomedical Engineering, Yonsei University, Wonju, Republic of Korea.
  • Department of Biomedical Engineering, Korea University, Seoul, Republic of Korea.
  • Division of Bio-Medical Science & Technology, KIST School, Korea University of Science and Technology (UST), Seoul, Republic of Korea.
  • KHU-KIST Department of Converging Science and Technology, Kyung Hee University, Seoul, Republic of Korea.

ORCID-Profile: Jaehong Key

Zitieren

APA

Choi, W., Cho, H., Jang, H., Park, H., Youn, I., Han, S., & Key, J. (2025). A Dual-Targeted Therapy with Fucoidan-Functionalized Thrombolytic Discoidal Microparticles for Pulmonary Thromboembolism. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s527596

Vancouver

Choi W, Cho H, Jang H, Park H, Youn I, Han S, et al. A Dual-Targeted Therapy with Fucoidan-Functionalized Thrombolytic Discoidal Microparticles for Pulmonary Thromboembolism. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s527596

BibTeX
@article{Choi2025,
  author = {Choi, Wonseok and Cho, Hyeyoun and Jang, Hwijin and Park, Hyewon and Youn, Inchan and Han, Sungmin and Key, Jaehong},
  title = {A Dual-Targeted Therapy with Fucoidan-Functionalized Thrombolytic Discoidal Microparticles for Pulmonary Thromboembolism},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s527596}
}
Kostenlos starten →